Osteogenic effect of exosomes derived by bEnd.3 cells: an in vitro study

傅德皓,刘慧敏,李锐,耿永涛,崔永志,刘平,梁涛
DOI: https://doi.org/10.3760/cma.j.cn421213-20200727-01267
2021-01-01
Abstract:Objective:To investigate the osteogenic effect of exosomes derived by mouse brain microvascular endothelial cell line bEnd.3 on bone marrow mesenchymal stem cells (BMSCs).Methods:Ultracentrifuge was used to extract the exosomes derived by brain-derived endothelial cells.3 (bEnd.3) cells bEnd.3 cells derived exosomes (b-Exo). Transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA) and Western blotting were use to characterize the exosomes. Alizarin red staining was used to detect the osteogenic effects of the exosomes. The relative messenger ribonucleic acid (mRNA) expression of osteogenic-related genes runt-related transcription factor 2 (Runx2), osteopontin and osteocalcin was detected by reverse transcriptase-polymerase chain reaction (RT-PCR).Results:TEM showed that the particles presented a typical vesicle-like shape. NTA manifested the concentration of Exo was 7.5×10 10 particles/ml and the diameter was (100.0±7.3) nm. The b-Exo could enhance the BMSCs matrix mineralization and increase the mRNA expression of osteogenic-related genes Runx2, osteopontin and osteocalcin compared to the controls (8.28±0.34 vs. 3.71±0.40, t=4.974, P<0.01; 9.19±1.91 vs. 4.09±0.88, t=5.562, P<0.01; 10.31±1.67 vs. 5.32±0.31, t=5.432, P<0.01). Conclusion:The b-Exo could promote the osteogenic performance of BMSCs and may be applied to the bone regeneration and the cell-free treatment of osteoporosis in the near future.
What problem does this paper attempt to address?